NHGRI, Partners Start Drug Repurposing Collaboration | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –The National Institutes of Health said today that it has inked a research collaboration agreement with The University of Kansas Medical Center and the Leukemia and Lymphoma Society (LLS) to accelerate development of potential therapeutics for rare blood cancers into proof-of-concept studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.